Neuronetics Announces 5-Year Exclusive Partnership with Transformations Care NetworkGlobeNewsWire • 03/07/24
Neuronetics Reports Record Fourth Quarter and Record Full Year 2023 Financial and Operating ResultsGlobeNewsWire • 03/05/24
Neuronetics to Report Fourth Quarter 2023 Financial and Operating Results and Host Conference CallGlobeNewsWire • 02/20/24
Neuronetics Launches Latest Evolution in its TrakStar® Patient Data Management SystemGlobeNewsWire • 02/12/24
Neuronetics Reports Preliminary Fourth Quarter and Fiscal Year 2023 Financial ResultsGlobeNewsWire • 01/08/24
Neuronetics Receives 510(k) Clearance for NeuroSite™ Coil Placement AccessoryGlobeNewsWire • 12/18/23
Neuronetics to Present at the 35th Annual Piper Sandler Healthcare ConferenceGlobeNewsWire • 11/15/23
NeuroStar Elevates Depression Treatment with Cutting-Edge Technology AdvancementsGlobeNewsWire • 11/13/23
Neuronetics Announces Continued Momentum from Health Plans for TMS Therapy CoverageGlobeNewsWire • 11/09/23
Neuronetics to Report Third Quarter 2023 Financial and Operating Results and Host Conference CallGlobeNewsWire • 10/24/23
Brain Stimulation Highlights Best Practices for Optimal TMS Treatment OutcomesGlobeNewsWire • 10/16/23
Neuronetics Draws Down Remaining $22.5 Million Available Under Credit FacilityGlobeNewsWire • 10/03/23
In Recognition of Suicide Prevention Month, NeuroStar Voices Portal Amplifies Stories of Real People Beating DepressionGlobeNewsWire • 09/12/23
Neuronetics Revolutionizes Patient Communication and Provider Support Through Its Exclusive TrakStar® PlatformGlobeNewsWire • 08/14/23
Neuronetics (STIM) Upgraded to Buy: What Does It Mean for the Stock?Zacks Investment Research • 08/11/23